145 Cost-effectiveness of botulinum neurotoxin A versus surgery for drooling: a randomized clinical trial 6 REFERENCES 1. van der Burg J, Jongerius P, van Limbeek J, van Hulst K, Rotteveel J. Drooling in children with cerebral palsy: a qualitative method to evaluate parental perceptions of its impact on daily life, social interaction, and self-esteem. Int J Rehabil Res 2006; 29: 179–82. 2. Van der Burg JJ, Jongerius PH, Van Hulst K, Van Limbeek J, Rotteveel JJ. Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care. Dev Med Child Neurol 2006; 48: 103–7. 3. van der Burg JJ, Jongerius PH, van Limbeek J, van Hulst K, Rotteveel JJ. Social interaction and selfesteem of children with cerebral palsy after treatment for severe drooling. Eur J Pediatr 2006; 165: 37–41. 4. Kok SE, van der Burg JJ, van Hulst K, Erasmus CE, van den Hoogen FJ. The impact of submandibular duct relocation on drooling and the well-being of children with neurodevelopmental disabilities. Int J Pediatr Otorhinolaryngol 2016; 88: 173–8. 5. Scheffer AR, Erasmus C, van Hulst K, van Limbeek J, Jongerius PH, van den Hoogen FJ. Efficacy and duration of botulinum toxin treatment for drooling in 131 children. Arch Otolaryngol Head Neck Surg 2010; 136: 873–7. 6. El-Hakim H, Richards S, Thevasagayam MS. Major salivary duct clipping for control problems in developmentally challenged children. Arch Otolaryngol Head Neck Surg 2008; 134: 470–4. 7. van Hulst K, Kouwenberg CV, Jongerius PH, et al. Negative effects of submandibular botulinum neurotoxin A injections on oral motor function in children with drooling due to central nervous system disorders. Dev Med Child Neurol 2017; 59: 531–7. 8. Formeister EJ, Dahl JP, Rose AS. Surgical management of chronic sialorrhea in pediatric patients: 10year experience from one tertiary care institution. Int J Pediatr Otorhinolaryngol 2014; 78: 1387–92. 9. Bekkers S, Pruijn IMJ, Van Hulst K, et al. Submandibular duct ligation after botulinum neurotoxin A treatment of drooling in children with cerebral palsy. Dev Med Child Neurol 2020; 62: 861–7. 10. Bekkers S, Delsing CP, Kok SE, et al. Randomized controlled trial comparing botulinum vs surgery for drooling in neurodisabilities. Neurology 2019; 92: e1195–204. 11. Bekkers S, van Hulst K, Erasmus CE, Delsing CP, Scheffer ART, van den Hoogen FJA. An evaluation of predictors for success of two-duct ligation for drooling in neurodisabilities. J Neurol 2020; 267: 1508–15. 12. Delsing CPA, Bekkers S, van Hulst K, Erasmus CE, van den Hoogen FJA. Unsuccessful submandibular duct surgery for anterior drooling: surgical failure or parotid gland salivation? Int J Pediatr Otorhinolaryngol 2019; 123: 132–7. 13. Thomas-Stonell N, Greenberg J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia 1988; 3: 73–8. 14. Van Hulst K, Van Der Burg JJ, Jongerius PH, Geurts AC, Erasmus CE. Changes in severity and impact of drooling after submandibular gland botulinum neurotoxin A injections in children with neurodevelopmental disabilities. Dev Med Child Neurol 2020; 62: 354–62. 15. van Hulst K, Lindeboom R, van der Burg J, Jongerius P. Accurate assessment of drooling severity with the 5-minute drooling quotient in children with developmental disabilities. Dev Med Child
RkJQdWJsaXNoZXIy MjY0ODMw